Managing Myeloma
- 2011-06-06 - Dr. Tony Coles, CEO of Onyx on Potential Cancer Drug Carfilzomib -- CNBC Business
- 2011-06-05 - ImmunoGen Reports Positive Data On IMGN901 In Treatment Of Multiple Myeloma
- 2011-06-04 - ASCO 2011 Multiple Myeloma Update – Days 1 And 2 -- The Myeloma Beacon
- 2011-06-03 - Study Suggests Longer Infusion Time Does Not Improve Safety Of Zoledronic Acid For Myeloma Patients -- The Myeloma Beacon
- 2011-06-02 - Multiple Myeloma Research Consortium Announces Data Presentations at the 2011 ASCO Annual Meeting
- 2011-06-01 - Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including a Phase III trial in progress of panobinostat plus bortezomib in relapsed/refractory multiple myeloma: PANORAMA-1 -- Reuters
- 2011-06-01 - FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma -- PR Newswire
- 2011-06-01 - Experts Draft Guidelines For The Prevention Of Blood Clots In Multiple Myeloma Patients (IMW 2011) -- Multiple Myeloma Beacon
- 2011-06-01 - Matt Damon Honors Mass General Hospital, Dad, Kent, Reveals he is Suffering From Multiple Myeloma -- Boston Herald
- 2011-05-31 - ImmunoGen, Inc. Announces Clinical Presentations at the ASCO 2011 Annual Meeting -- Traders Huddle.com
- 2011-05-31 - Roundtable: The World's Best Biotechs -- The Motley Fool
- 2011-05-30 - Stevie Wonder Recognized For Philanthropy -- RT News
- 2011-05-26 - The Business of Fighting Cancer -- Harvard Magazine
- 2011-05-26 - Pat’s Place: Following Multiple Myeloma Research Can Be Frustrating, Yet Exhilarating! -- The Myeloma Beacon
- 2011-05-26 - Adaptimmune Announces Opening Of Phase I/II Clinical Trial In Multiple Myeloma -- Medical News Today